Skip to main content
Top
Published in: Canadian Journal of Anesthesia/Journal canadien d'anesthésie 10/2011

01-10-2011 | Case Reports/Case Series

Recurarization after sugammadex reversal in an obese patient

Authors: Frédérique Le Corre, MD, Salmi Nejmeddine, MD, Chérif Fatahine, MD, Claude Tayar, MD, Jean Marty, MD, Benoît Plaud, MD, PhD

Published in: Canadian Journal of Anesthesia/Journal canadien d'anesthésie | Issue 10/2011

Login to get access

Abstract

Purpose

We report a case that involved immediate postoperative respiratory failure necessitating tracheal intubation, which was possibly related to recurarization after sugammadex reversal.

Clinical findings

A 54-yr-old woman weighing 115-kg was scheduled for laparoscopic repair of abdominal dehiscence under general anesthesia. Muscle relaxation was induced and maintained with rocuronium (170 mg iv total dose). At the end of the 170-min procedure, two twitches were visualized after supramaximal train-of-four (TOF) stimulation at the adductor pollicis muscle, and the patient’s central core temperature was 35.6°C. Sugammadex 200 mg iv (1.74 mg·kg−1) was administered. With the patient fully awake, a TOF ratio 0.9 was obtained five minutes later. The tracheal tube was then removed, and the patient was transferred to the postanesthesia care unit. Ten minutes later, the patient presented respiratory failure necessitating tracheal intubation and sedation with propofol. One TOF response only was visualized at the adductor pollicis muscle. Another dose of sugammadex 200 mg iv was administered. Forty-five minutes later, the patient was fully awake and her trachea was extubated after repeated measures of the TOF ratio (≥ 0.9) at the adductor pollicis muscle. The patient fully recovered without sequelae, further complication, or prolonged hospital stay.

Conclusion

Shortly after tracheal extubation, an obese patient experienced respiratory failure necessitating tracheal intubation and an additional dose of sugammadex. This occurred despite initial reversal of neuromuscular blockade with an appropriate dose of sugammadex 2 mg·kg−1 iv given at two responses to TOF stimulation.
Literature
1.
go back to reference Plaud B, Debaene B, Donati F, Marty J. Residual paralysis after emergence from anesthesia. Anesthesiology 2010; 112: 1013-22.PubMedCrossRef Plaud B, Debaene B, Donati F, Marty J. Residual paralysis after emergence from anesthesia. Anesthesiology 2010; 112: 1013-22.PubMedCrossRef
2.
go back to reference Blobner M, Eriksson LI, Scholz J, Motsch J, Della Rocca G, Prins ME. Reversal of rocuronium-induced neuromuscular blockade with sugammadex compared with neostigmine during sevoflurane anaesthesia: results of a randomised, controlled trial. Eur J Anaesthesiol 2010; 27: 874-81.PubMedCrossRef Blobner M, Eriksson LI, Scholz J, Motsch J, Della Rocca G, Prins ME. Reversal of rocuronium-induced neuromuscular blockade with sugammadex compared with neostigmine during sevoflurane anaesthesia: results of a randomised, controlled trial. Eur J Anaesthesiol 2010; 27: 874-81.PubMedCrossRef
3.
go back to reference Khuenl-Brady KS, Wattwil M, Vanacker BF, Lora-Tamayo JI, Rietbergen H, Alvarez-Gomez JA. Sugammadex provides faster reversal of vecuronium-induced neuromuscular blockade compared with neostigmine, a multicenter, randomized, controlled trial. Anesth Analg 2010; 110: 64-73.PubMedCrossRef Khuenl-Brady KS, Wattwil M, Vanacker BF, Lora-Tamayo JI, Rietbergen H, Alvarez-Gomez JA. Sugammadex provides faster reversal of vecuronium-induced neuromuscular blockade compared with neostigmine, a multicenter, randomized, controlled trial. Anesth Analg 2010; 110: 64-73.PubMedCrossRef
4.
go back to reference Eleveld DJ, Kuizenga K, Proost JH, Wierda JM. A temporary decrease in twitch response during reversal of rocuronium-induced muscle relaxation with a small dose of sugammadex. Anesth Analg 2007; 104: 582-4.PubMedCrossRef Eleveld DJ, Kuizenga K, Proost JH, Wierda JM. A temporary decrease in twitch response during reversal of rocuronium-induced muscle relaxation with a small dose of sugammadex. Anesth Analg 2007; 104: 582-4.PubMedCrossRef
5.
go back to reference Drobnik L, Sparr HJ, Thorn SE, et al. A randomized simultaneous comparison of acceleromyography with a peripheral nerve stimulator for assessing reversal of rocuronium-induced neuromuscular blockade with sugammadex. Eur J Anaesthesiol 2010; 27: 866-73.PubMedCrossRef Drobnik L, Sparr HJ, Thorn SE, et al. A randomized simultaneous comparison of acceleromyography with a peripheral nerve stimulator for assessing reversal of rocuronium-induced neuromuscular blockade with sugammadex. Eur J Anaesthesiol 2010; 27: 866-73.PubMedCrossRef
6.
go back to reference Fuchs-Buder T. Less is not always more: sugammadex and the risk of under-dosing. Eur J Anaesthesiol 2010; 27: 849-50.PubMedCrossRef Fuchs-Buder T. Less is not always more: sugammadex and the risk of under-dosing. Eur J Anaesthesiol 2010; 27: 849-50.PubMedCrossRef
7.
go back to reference Dahaba AA, von Klobucar F, Rehak PH, List WF. The neuromuscular transmission module versus the relaxometer mechanomyograph for neuromuscular block monitoring. Anesth Analg 2002; 94: 591-6.PubMedCrossRef Dahaba AA, von Klobucar F, Rehak PH, List WF. The neuromuscular transmission module versus the relaxometer mechanomyograph for neuromuscular block monitoring. Anesth Analg 2002; 94: 591-6.PubMedCrossRef
8.
go back to reference Vanacker BF, Vermeyen KM, Struys MM, et al. Reversal of rocuronium-induced neuromuscular block with the novel drug sugammadex is equally effective under maintenance anesthesia with propofol or sevoflurane. Anesth Analg 2007; 104: 563-8.PubMedCrossRef Vanacker BF, Vermeyen KM, Struys MM, et al. Reversal of rocuronium-induced neuromuscular block with the novel drug sugammadex is equally effective under maintenance anesthesia with propofol or sevoflurane. Anesth Analg 2007; 104: 563-8.PubMedCrossRef
9.
go back to reference Motamed C, Kirov K, Combes X, Duvaldestin P. Comparison between the Datex-Ohmeda M-NMT module and a force-displacement transducer for monitoring neuromuscular blockade. Eur J Anaesthesiol 2003; 20: 467-9.PubMedCrossRef Motamed C, Kirov K, Combes X, Duvaldestin P. Comparison between the Datex-Ohmeda M-NMT module and a force-displacement transducer for monitoring neuromuscular blockade. Eur J Anaesthesiol 2003; 20: 467-9.PubMedCrossRef
10.
go back to reference Hemmerling TM, Donati F. The M-NMT mechanosensor cannot be considered as a reliable clinical neuromuscular monitor in daily anesthesia practice. Anesth Analg 2002; 95: 1826-7.PubMedCrossRef Hemmerling TM, Donati F. The M-NMT mechanosensor cannot be considered as a reliable clinical neuromuscular monitor in daily anesthesia practice. Anesth Analg 2002; 95: 1826-7.PubMedCrossRef
11.
go back to reference Kopman AF. Is the Datex-Ohmeda M-NMT module a research quality instrument? Eur J Anaesthesiol 2004; 21: 833-4.PubMed Kopman AF. Is the Datex-Ohmeda M-NMT module a research quality instrument? Eur J Anaesthesiol 2004; 21: 833-4.PubMed
13.
go back to reference Staals LM, Snoeck MM, Driessen JJ, et al. Reduced clearance of rocuronium and sugammadex in patients with severe to end-stage renal failure: a pharmacokinetic study. Br J Anaesth 2010; 104: 31-9.PubMedCrossRef Staals LM, Snoeck MM, Driessen JJ, et al. Reduced clearance of rocuronium and sugammadex in patients with severe to end-stage renal failure: a pharmacokinetic study. Br J Anaesth 2010; 104: 31-9.PubMedCrossRef
14.
go back to reference Meyhoff CS, Lund J, Jenstrup MT, et al. Should dosing of rocuronium in obese patients be based on ideal or corrected body weight? Anesth Analg 2009; 109: 787-92.PubMedCrossRef Meyhoff CS, Lund J, Jenstrup MT, et al. Should dosing of rocuronium in obese patients be based on ideal or corrected body weight? Anesth Analg 2009; 109: 787-92.PubMedCrossRef
15.
go back to reference Illman HL, Laurila P, Antila H, Meretaja OA, Alahuhta S, Olkkola KT. The duration of residual neuromuscular block after administration of neostigmine or sugammadex at two visible twitches during train-of-four monitoring. Anesth Analg 2011; 112: 63-8.PubMedCrossRef Illman HL, Laurila P, Antila H, Meretaja OA, Alahuhta S, Olkkola KT. The duration of residual neuromuscular block after administration of neostigmine or sugammadex at two visible twitches during train-of-four monitoring. Anesth Analg 2011; 112: 63-8.PubMedCrossRef
16.
go back to reference Plaud B. Sugammadex: something new to improve patient safety or simply a gadget? (French). Ann Fr Anesth Reanim 2009; 28: S64-9.PubMed Plaud B. Sugammadex: something new to improve patient safety or simply a gadget? (French). Ann Fr Anesth Reanim 2009; 28: S64-9.PubMed
17.
18.
go back to reference Miller RD, Ward TA. Monitoring and pharmacologic reversal of a nondepolarizing neuromuscular blockade should be routine. Anesth Analg 2010; 111: 3-5.PubMedCrossRef Miller RD, Ward TA. Monitoring and pharmacologic reversal of a nondepolarizing neuromuscular blockade should be routine. Anesth Analg 2010; 111: 3-5.PubMedCrossRef
19.
go back to reference Viby-Mogensen J, Claudius C. Evidence-based management of neuromuscular block. Anesth Analg 2010; 111: 1-2.PubMedCrossRef Viby-Mogensen J, Claudius C. Evidence-based management of neuromuscular block. Anesth Analg 2010; 111: 1-2.PubMedCrossRef
Metadata
Title
Recurarization after sugammadex reversal in an obese patient
Authors
Frédérique Le Corre, MD
Salmi Nejmeddine, MD
Chérif Fatahine, MD
Claude Tayar, MD
Jean Marty, MD
Benoît Plaud, MD, PhD
Publication date
01-10-2011
Publisher
Springer-Verlag
Published in
Canadian Journal of Anesthesia/Journal canadien d'anesthésie / Issue 10/2011
Print ISSN: 0832-610X
Electronic ISSN: 1496-8975
DOI
https://doi.org/10.1007/s12630-011-9554-y

Other articles of this Issue 10/2011

Canadian Journal of Anesthesia/Journal canadien d'anesthésie 10/2011 Go to the issue